About Dellarex Biotec
Dellarex Biotec is a company based in Dombivli (India). It operates as a B2B and B2C. Dellarex Biotec offers products and services including Oncology Pharmaceuticals, Urology Pharmaceuticals, Virology Pharmaceuticals, Ophthalmology Pharmaceuticals, and Nephrology Pharmaceuticals. Dellarex Biotec operates in a competitive market with competitors including Blue Rock Therapeutics, Impel Pharmaceuticals, CellCarta, Ascend and RiboPro, among others.
- Headquarter Dombivli, India
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Dellarex Biotec Private Limited
- Date of Incorporation 19 Sep, 2016
- Jurisdiction Thane, Maharashtra, India
-
Annual Revenue
$2.46 M (USD)-12.32as on Mar 31, 2023
-
Net Profit
$26.69 K (USD)-57.26as on Mar 31, 2023
-
EBITDA
$60.9 K (USD)-35.17as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Dellarex Biotec
Dellarex Biotec offers a comprehensive portfolio of products and services, including Oncology Pharmaceuticals, Urology Pharmaceuticals, Virology Pharmaceuticals, Ophthalmology Pharmaceuticals, and Nephrology Pharmaceuticals.
Distribution of drugs for cancer treatment and care.
Supply of medications for urological conditions.
Provision of antiviral drugs for viral infections.
Distribution of eye care medications and products.
Supply of drugs for kidney-related disorders.
Funding Insights of Dellarex Biotec
Detailed funding history for Dellarex Biotec
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Dellarex Biotec
Investment portfolio details for Dellarex Biotec
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Dellarex Biotec
Detailed financials for Dellarex Biotec
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Dellarex Biotec Comparisons
Peer comparison for Dellarex Biotec
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Dellarex Biotec
Dellarex Biotec operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Blue Rock Therapeutics, Impel Pharmaceuticals, CellCarta, Ascend and RiboPro, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Stem cell therapies are developed for cardiovascular and neurological diseases.
|
|
| Locked | Locked | Locked |
Transformative therapies are developed and commercialized through specialized services.
|
|
| Locked | Locked | Locked |
Histopathology and genomics services are offered by the CRO.
|
|
| Locked | Locked | Locked |
Online insurance payments and premium financing are enabled for businesses.
|
|
| Locked | Locked | Locked |
Online supplier and developer of RNA based products
|
|
| Locked | Locked | Locked |
Stem cell drug research and clinical trial services are provided.
|
Detailed competitors of Dellarex Biotec
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Dellarex Biotec
Complete news archive for Dellarex Biotec
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dellarex Biotec
Dellarex Biotec is headquartered in Dombivli, India. It is registered at Dombivli, Maharashtra, India.
Annual revenue of Dellarex Biotec is $2.46M as on Mar 31, 2023.
Dellarex Biotec Is A Pharmaceutical Distribution Company Based In Mumbai, India, Offering Affordable, Effective Pharmaceuticals In Categories Like Oncology And Urology. They Focus On Innovative Programs For Healthcare Enhancement, Ensuring Prompt Delivery Across The Country. The Company Serves As A Preferred Partner For Top Pharma Brands, Handling Bulk Orders And Maintaining Strict Regulatory Compliance.
Dellarex Biotec's top competitors include Blue Rock Therapeutics, Ascend and CellCarta.
Dellarex Biotec offers Oncology Pharmaceuticals, Urology Pharmaceuticals, Virology Pharmaceuticals, Ophthalmology Pharmaceuticals, and Nephrology Pharmaceuticals.